Skip to main content
. 2013 Apr 25;121(22):4439–4442. doi: 10.1182/blood-2013-03-490003

Table 1.

Annual price estimates, by region, of drugs approved for the treatment of CML

Country Price in thousands of US dollars (rounded to nearest $0.5 thousand)
Imatinib Nilotinib Dasatinib
United States 92 115.5 123.5
Germany* 54 60 90
United Kingdom 33.5 33.5 48.5
Canada 46.5 48 62.5
Norway 50.5 61 82.5
France 40 51.5 71
Italy 31 43 54
South Korea 28.5 26 22
Mexico 29 39 49.5
Argentina 52 73.5 80
Australia 46.5 53.5 60
Japan 43 55 72
China 46.5 75 61.5
Russia 24 48.5 56.5
South Africa 43 28 54.5

Prices in the United States from the Red Book online.1 Other prices provided by CML experts from their countries.

*

In Germany, a new rule, the “Pharmaceutical Market Restructuring Act” or AMNOG (arzneimittelneuordnungsgesetz), took effect in January 2011, by which the prices of new drugs are negotiated according to their benefit in comparison with other drugs on the market for the same indication. Similar rules or laws are also in effect in other European countries.11 Prices of drugs in Germany may directly or indirectly influence drug prices in 31 countries.12